Specify a stock or a cryptocurrency in the search bar to get a summary
Well Lead Med Co Ltd
603309Well Lead Medical Co., Ltd. engages in the development, production, and sale of medical devices in anaesthesia, urology, endourology, respiratory, pain management, and hemodialysis areas worldwide. It manufactures and sells urology products, including Foley catheter, Nelaton catheters, urine collection products, and accessories; endourology products, such as the ClearPetra family system, ureterorenoscope, guide wires, ureteral stent, and stone retrieval basket; anesthesia products, comprising endotracheal tubes, intubation accessories, laryngeal masks, endobronchial tubes, tracheostomy tubes, anesthesia breathing circuits and accessories, and nasopharyngeal and oropharyngeal airway products; respiratory products, including oxygen and aerosol therapy products, and capnography mask and cannula products; drainage/suction/gastroenterology products, such as drainage systems, Yankauer handles, suction catheters, and stomach and feeding tubes; hemodialysis blood tubing set; home care products, including male external catheter and Convicath intermittent catheter; and ambulatory infusion pump for pain management. The company was founded in 1998 and is headquartered in Guangzhou, China. Address: 47 Guomao Avenue South, Guangzhou, China, 511434
Analytics
WallStreet Target Price
307.2 CNYP/E ratio
18.1892Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 603309
Dividend Analytics 603309
Dividend growth over 5 years
195 %Continuous growth
1 yearPayout Ratio 5 years average
35 %Dividend History 603309
Stock Valuation 603309
Financials 603309
Results | 2019 | Dynamics |